Fundamental analysis in ilmn stock price forecast points to favorable gross margin trends, topping 68% in the latest earnings report. This metric is essential in sustaining competitive pricing without sacrificing R&D investment. On February 4, Eric Lefkofsky, founder and CEO of Tempus AI, appeared on CNBC to talk about the impact of generative AI in diagnostics healthcare, among other things. He was of the view that generative AI and large language models aren’t more impactful in any other avenue as much as they are in healthcare. Diagnostics sit at the center of healthcare, as almost every other major decision a doctor makes is undertaken after ordering some kind of laboratory test. If we can make diagnostics more intelligent, it would be possible to route patients to the best possible and most optimal therapy. Find stocks with ease across diverse datasets and filters Investor calls reviewing ilmn stock price forecast highlight management’s guidance upgrades for FY2024 EPS. Revised expectations may prompt target price increases among covering analysts.